Barriers & facilitators to managing hypertension, T2DM & obesity - V1
Research type
Research Study
Full title
What are the barriers and facilitators to managing hypertension, type 2 diabetes mellitus and obesity in East Anglia?
IRAS ID
341737
Contact name
Josette Bettany-Saltikov
Contact email
Sponsor organisation
Teesside Univeristy
Duration of Study in the UK
2 years, 5 months, 1 days
Research summary
Patients diagnosed with hypertension, type 2 diabetes and obesity, and clinicians involved in the management, will be invited to participate in semi-structured one-to-one interviews to explore their experiences around the clinical management of these important conditions. The interviews will seek to highlight their lived experience to determine barriers and facilitators to patients engaging with clinical treatment and the ways in which they believe their care/experience could be improved.
Participants will be contacted by the designated gatekeeper (Laura Lyons, Practice Manager) in order to invite them to participate in the study. Two groups of participants will be created, one for patients diagnosed with the conditions and one for the clinicians who have an active role in chronic disease management.
Purposive sampling will be used in the study. Potential participants will be screened from the search results and selected for invitation based on meeting the inclusion criteria. It is anticipated that some participants will be identified in the search who may meet the exclusion criteria (i.e. where disease management is being lead from outside primary care).
Potential participants will be invited by the gatekeeper and recruitment will continue until either data saturation (defined as no new themes being generated) or a maximum number of 30 participants have been recruited (allowing for realistic management of the data). Groups will unlikely be of equal size due to a smaller number of available suitable clinicians.
The data obtained from the interviews will be subjected to thematic analysis highlighting key themes within the data, allowing deep analysis of the lived experience of patients and clinicians. The aim of the research is obtain an understanding of the challenges of engaging patients in chronic disease management (for the stated conditions) and promote practice change to improving patient care locally, contributing to reducing potential health inequalities and improving local population health.
REC name
London - West London & GTAC Research Ethics Committee
REC reference
24/PR/1533
Date of REC Opinion
14 Jan 2025
REC opinion
Further Information Favourable Opinion